The Market Reports

Index

1 Diagnostic Radiopharmaceuticals Market Overview
1.1 Product Overview and Scope of Diagnostic Radiopharmaceuticals
1.2 Diagnostic Radiopharmaceuticals Segment by Type
1.2.1 Global Diagnostic Radiopharmaceuticals Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Technetium 99
1.2.3 Fluorine 18
1.2.4 Other
1.3 Diagnostic Radiopharmaceuticals Segment by Application
1.3.1 Global Diagnostic Radiopharmaceuticals Sales Comparison by Application: (2021-2027)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Diagnostic Radiopharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global Diagnostic Radiopharmaceuticals Revenue 2016-2027
1.4.2 Global Diagnostic Radiopharmaceuticals Sales 2016-2027
1.4.3 Diagnostic Radiopharmaceuticals Market Size by Region: 2016 Versus 2021 Versus 2027

2 Diagnostic Radiopharmaceuticals Market Competition by Manufacturers
2.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Manufacturers (2016-2021)
2.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Diagnostic Radiopharmaceuticals Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Diagnostic Radiopharmaceuticals Manufacturing Sites, Area Served, Product Type
2.5 Diagnostic Radiopharmaceuticals Market Competitive Situation and Trends
2.5.1 Diagnostic Radiopharmaceuticals Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Diagnostic Radiopharmaceuticals Players Market Share by Revenue
2.5.3 Global Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Diagnostic Radiopharmaceuticals Retrospective Market Scenario by Region
3.1 Global Diagnostic Radiopharmaceuticals Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Diagnostic Radiopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.3.1 North America Diagnostic Radiopharmaceuticals Sales by Country
3.3.2 North America Diagnostic Radiopharmaceuticals Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.4.1 Europe Diagnostic Radiopharmaceuticals Sales by Country
3.4.2 Europe Diagnostic Radiopharmaceuticals Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Diagnostic Radiopharmaceuticals Market Facts & Figures by Region
3.5.1 Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region
3.5.2 Asia Pacific Diagnostic Radiopharmaceuticals Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.6.1 Latin America Diagnostic Radiopharmaceuticals Sales by Country
3.6.2 Latin America Diagnostic Radiopharmaceuticals Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.7.1 Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country
3.7.2 Middle East and Africa Diagnostic Radiopharmaceuticals Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Diagnostic Radiopharmaceuticals Historic Market Analysis by Type
4.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2016-2021)
4.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2016-2021)
4.3 Global Diagnostic Radiopharmaceuticals Price by Type (2016-2021)

5 Global Diagnostic Radiopharmaceuticals Historic Market Analysis by Application
5.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2016-2021)
5.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2016-2021)
5.3 Global Diagnostic Radiopharmaceuticals Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Cardinal Health
6.1.1 Cardinal Health Corporation Information
6.1.2 Cardinal Health Description and Business Overview
6.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Cardinal Health Diagnostic Radiopharmaceuticals Product Portfolio
6.1.5 Cardinal Health Recent Developments/Updates
6.2 GE Healthcare
6.2.1 GE Healthcare Corporation Information
6.2.2 GE Healthcare Description and Business Overview
6.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GE Healthcare Diagnostic Radiopharmaceuticals Product Portfolio
6.2.5 GE Healthcare Recent Developments/Updates
6.3 Curium Pharma
6.3.1 Curium Pharma Corporation Information
6.3.2 Curium Pharma Description and Business Overview
6.3.3 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Curium Pharma Diagnostic Radiopharmaceuticals Product Portfolio
6.3.5 Curium Pharma Recent Developments/Updates
6.4 Jubilant Pharma
6.4.1 Jubilant Pharma Corporation Information
6.4.2 Jubilant Pharma Description and Business Overview
6.4.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Portfolio
6.4.5 Jubilant Pharma Recent Developments/Updates
6.5 Bracco Imaging
6.5.1 Bracco Imaging Corporation Information
6.5.2 Bracco Imaging Description and Business Overview
6.5.3 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Bracco Imaging Diagnostic Radiopharmaceuticals Product Portfolio
6.5.5 Bracco Imaging Recent Developments/Updates
6.6 Advanced Accelerator Applications
6.6.1 Advanced Accelerator Applications Corporation Information
6.6.2 Advanced Accelerator Applications Description and Business Overview
6.6.3 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Portfolio
6.6.5 Advanced Accelerator Applications Recent Developments/Updates
6.7 SIEMENS
6.6.1 SIEMENS Corporation Information
6.6.2 SIEMENS Description and Business Overview
6.6.3 SIEMENS Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.4.4 SIEMENS Diagnostic Radiopharmaceuticals Product Portfolio
6.7.5 SIEMENS Recent Developments/Updates
6.8 China Isotope & Radiation
6.8.1 China Isotope & Radiation Corporation Information
6.8.2 China Isotope & Radiation Description and Business Overview
6.8.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.8.4 China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Portfolio
6.8.5 China Isotope & Radiation Recent Developments/Updates
6.9 Dongcheng Pharmaceutical Group
6.9.1 Dongcheng Pharmaceutical Group Corporation Information
6.9.2 Dongcheng Pharmaceutical Group Description and Business Overview
6.9.3 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Portfolio
6.9.5 Dongcheng Pharmaceutical Group Recent Developments/Updates
6.10 Lantheus
6.10.1 Lantheus Corporation Information
6.10.2 Lantheus Description and Business Overview
6.10.3 Lantheus Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Lantheus Diagnostic Radiopharmaceuticals Product Portfolio
6.10.5 Lantheus Recent Developments/Updates
6.11 Eli Lilly
6.11.1 Eli Lilly Corporation Information
6.11.2 Eli Lilly Diagnostic Radiopharmaceuticals Description and Business Overview
6.11.3 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Eli Lilly Diagnostic Radiopharmaceuticals Product Portfolio
6.11.5 Eli Lilly Recent Developments/Updates

7 Diagnostic Radiopharmaceuticals Manufacturing Cost Analysis
7.1 Diagnostic Radiopharmaceuticals Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals
7.4 Diagnostic Radiopharmaceuticals Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Diagnostic Radiopharmaceuticals Distributors List
8.3 Diagnostic Radiopharmaceuticals Customers

9 Diagnostic Radiopharmaceuticals Market Dynamics
9.1 Diagnostic Radiopharmaceuticals Industry Trends
9.2 Diagnostic Radiopharmaceuticals Growth Drivers
9.3 Diagnostic Radiopharmaceuticals Market Challenges
9.4 Diagnostic Radiopharmaceuticals Market Restraints

10 Global Market Forecast
10.1 Diagnostic Radiopharmaceuticals Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Diagnostic Radiopharmaceuticals by Type (2022-2027)
10.2 Diagnostic Radiopharmaceuticals Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Diagnostic Radiopharmaceuticals by Application (2022-2027)
10.3 Diagnostic Radiopharmaceuticals Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Diagnostic Radiopharmaceuticals by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Diagnostic Radiopharmaceuticals Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Diagnostic Radiopharmaceuticals Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Diagnostic Radiopharmaceuticals Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Diagnostic Radiopharmaceuticals Covered in This Study
Table 5. Global Diagnostic Radiopharmaceuticals Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Diagnostic Radiopharmaceuticals Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Diagnostic Radiopharmaceuticals Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Diagnostic Radiopharmaceuticals Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Diagnostic Radiopharmaceuticals Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Diagnostic Radiopharmaceuticals Manufacturing Sites and Area Served
Table 11. Manufacturers Diagnostic Radiopharmaceuticals Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Diagnostic Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Radiopharmaceuticals as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Diagnostic Radiopharmaceuticals Sales by Region (2016-2021) & (K Units)
Table 16. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Table 17. Global Diagnostic Radiopharmaceuticals Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Diagnostic Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 19. North America Diagnostic Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 20. North America Diagnostic Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 22. Europe Diagnostic Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 23. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 24. Europe Diagnostic Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Diagnostic Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Diagnostic Radiopharmaceuticals Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
Table 30. Latin America Diagnostic Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Diagnostic Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 32. Latin America Diagnostic Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Diagnostic Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 38. Global Diagnostic Radiopharmaceuticals Sales (K Units) by Type (2016-2021)
Table 39. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 40. Global Diagnostic Radiopharmaceuticals Revenue (Million US$) by Type (2016-2021)
Table 41. Global Diagnostic Radiopharmaceuticals Revenue Share by Type (2016-2021)
Table 42. Global Diagnostic Radiopharmaceuticals Price (US$/Unit) by Type (2016-2021)
Table 43. Global Diagnostic Radiopharmaceuticals Sales (K Units) by Application (2016-2021)
Table 44. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 45. Global Diagnostic Radiopharmaceuticals Revenue (Million US$) by Application (2016-2021)
Table 46. Global Diagnostic Radiopharmaceuticals Revenue Share by Application (2016-2021)
Table 47. Global Diagnostic Radiopharmaceuticals Price (US$/Unit) by Application (2016-2021)
Table 48. Cardinal Health Corporation Information
Table 49. Cardinal Health Description and Business Overview
Table 50. Cardinal Health Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Cardinal Health Diagnostic Radiopharmaceuticals Product
Table 52. Cardinal Health Recent Developments/Updates
Table 53. GE Healthcare Corporation Information
Table 54. GE Healthcare Description and Business Overview
Table 55. GE Healthcare Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. GE Healthcare Diagnostic Radiopharmaceuticals Product
Table 57. GE Healthcare Recent Developments/Updates
Table 58. Curium Pharma Corporation Information
Table 59. Curium Pharma Description and Business Overview
Table 60. Curium Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Curium Pharma Diagnostic Radiopharmaceuticals Product
Table 62. Curium Pharma Recent Developments/Updates
Table 63. Jubilant Pharma Corporation Information
Table 64. Jubilant Pharma Description and Business Overview
Table 65. Jubilant Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Jubilant Pharma Diagnostic Radiopharmaceuticals Product
Table 67. Jubilant Pharma Recent Developments/Updates
Table 68. Bracco Imaging Corporation Information
Table 69. Bracco Imaging Description and Business Overview
Table 70. Bracco Imaging Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Bracco Imaging Diagnostic Radiopharmaceuticals Product
Table 72. Bracco Imaging Recent Developments/Updates
Table 73. Advanced Accelerator Applications Corporation Information
Table 74. Advanced Accelerator Applications Description and Business Overview
Table 75. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product
Table 77. Advanced Accelerator Applications Recent Developments/Updates
Table 78. SIEMENS Corporation Information
Table 79. SIEMENS Description and Business Overview
Table 80. SIEMENS Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. SIEMENS Diagnostic Radiopharmaceuticals Product
Table 82. SIEMENS Recent Developments/Updates
Table 83. China Isotope & Radiation Corporation Information
Table 84. China Isotope & Radiation Description and Business Overview
Table 85. China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. China Isotope & Radiation Diagnostic Radiopharmaceuticals Product
Table 87. China Isotope & Radiation Recent Developments/Updates
Table 88. Dongcheng Pharmaceutical Group Corporation Information
Table 89. Dongcheng Pharmaceutical Group Description and Business Overview
Table 90. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product
Table 92. Dongcheng Pharmaceutical Group Recent Developments/Updates
Table 93. Lantheus Corporation Information
Table 94. Lantheus Description and Business Overview
Table 95. Lantheus Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Lantheus Diagnostic Radiopharmaceuticals Product
Table 97. Lantheus Recent Developments/Updates
Table 98. Eli Lilly Corporation Information
Table 99. Eli Lilly Description and Business Overview
Table 100. Eli Lilly Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Eli Lilly Diagnostic Radiopharmaceuticals Product
Table 102. Eli Lilly Recent Developments/Updates
Table 103. Production Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. Diagnostic Radiopharmaceuticals Distributors List
Table 106. Diagnostic Radiopharmaceuticals Customers List
Table 107. Diagnostic Radiopharmaceuticals Market Trends
Table 108. Diagnostic Radiopharmaceuticals Growth Drivers
Table 109. Diagnostic Radiopharmaceuticals Market Challenges
Table 110. Diagnostic Radiopharmaceuticals Market Restraints
Table 111. Global Diagnostic Radiopharmaceuticals Sales Forecast by Type (2022-2027) & (K Units)
Table 112. Global Diagnostic Radiopharmaceuticals Sales Market Share Forecast by Type (2022-2027)
Table 113. Global Diagnostic Radiopharmaceuticals Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 114. Global Diagnostic Radiopharmaceuticals Revenue Market Share Forecast by Type (2022-2027)
Table 115. Global Diagnostic Radiopharmaceuticals Sales Forecast by Application (2022-2027) & (K Units)
Table 116. Global Diagnostic Radiopharmaceuticals Sales Market Share Forecast by Application (2022-2027)
Table 117. Global Diagnostic Radiopharmaceuticals Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 118. Global Diagnostic Radiopharmaceuticals Revenue Market Share Forecast by Application (2022-2027)
Table 119. Global Diagnostic Radiopharmaceuticals Sales Forecast by Region (2022-2027) & (K Units)
Table 120. Global Diagnostic Radiopharmaceuticals Sales Market Share Forecast by Region (2022-2027)
Table 121. Global Diagnostic Radiopharmaceuticals Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 122. Global Diagnostic Radiopharmaceuticals Revenue Market Share Forecast by Region (2022-2027)
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Diagnostic Radiopharmaceuticals
Figure 2. Global Diagnostic Radiopharmaceuticals Market Share by Type in 2020 & 2027
Figure 3. Technetium 99 Product Picture
Figure 4. Fluorine 18 Product Picture
Figure 5. Other Product Picture
Figure 6. Global Diagnostic Radiopharmaceuticals Market Share by Application in 2020 & 2027
Figure 7. Oncology
Figure 8. Cardiology
Figure 9. Other
Figure 10. Global Diagnostic Radiopharmaceuticals Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Diagnostic Radiopharmaceuticals Market Size 2016-2027 (US$ Million)
Figure 12. Global Diagnostic Radiopharmaceuticals Sales 2016-2027 (K Units)
Figure 13. Global Diagnostic Radiopharmaceuticals Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Diagnostic Radiopharmaceuticals Sales Share by Manufacturers in 2020
Figure 15. Global Diagnostic Radiopharmaceuticals Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Diagnostic Radiopharmaceuticals Players: Market Share by Revenue in 2020
Figure 17. Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Figure 19. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region in 2020
Figure 20. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
Figure 21. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region in 2020
Figure 22. U.S. Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Diagnostic Radiopharmaceuticals by Type (2016-2021)
Figure 47. Sales Market Share of Diagnostic Radiopharmaceuticals by Application (2016-2021)
Figure 48. Sales Market Share of Diagnostic Radiopharmaceuticals by Application in 2020
Figure 49. Revenue Share of Diagnostic Radiopharmaceuticals by Application (2016-2021)
Figure 50. Revenue Share of Diagnostic Radiopharmaceuticals by Application in 2020
Figure 51. Manufacturing Cost Structure of Diagnostic Radiopharmaceuticals
Figure 52. Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals
Figure 53. Diagnostic Radiopharmaceuticals Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed